Provided by Tiger Trade Technology Pte. Ltd.

C4 Therapeutics, Inc.

3.03
-0.0600-1.94%
Post-market: 3.00-0.0303-1.00%19:57 EST
Volume:2.50M
Turnover:7.42M
Market Cap:295.66M
PE:-2.39
High:3.10
Open:3.10
Low:2.87
Close:3.09
52wk High:3.65
52wk Low:1.09
Shares:97.58M
Float Shares:72.05M
Volume Ratio:0.48
T/O Rate:3.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2666
EPS(LYR):-1.2666
ROE:-44.44%
ROA:-18.43%
PB:1.15
PE(LYR):-2.39

Loading ...

Dec 12, 2023

Major Issues Report

Form 8-K - Current report
Dec 12, 2023

Major Issues Report

Form 8-K - Current report
Nov 20, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 01, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Sep 05, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Jul 25, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 20, 2023

Major Issues Report

Form 8-K - Current report
Jun 12, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 30, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 23, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 23, 2023

Major Issues Report

8-K/A [Amend] - Current report
Feb 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2023

Major Issues Report

8-K - Current report